These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3556742)

  • 1. Schistosomicides and DNA functioning.
    Pica-Mattoccia L; Cioli D; Archer S
    Biochem Soc Trans; 1987 Feb; 15(1):70-3. PubMed ID: 3556742
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
    Pica-Mattoccia L; Cioli D
    Am J Trop Med Hyg; 1985 Jan; 34(1):112-8. PubMed ID: 3838223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic and molecular aspects of drug resistance in Schistosoma mansoni].
    Pica L; Cioli D
    Ann Ist Super Sanita; 1986; 22(1):153-5. PubMed ID: 3752792
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on some derivatives of oxamniquine.
    el-Hamouly W; Pica-Mattoccia L; Cioli D; Schwartz HM; Archer S
    J Med Chem; 1988 Aug; 31(8):1629-31. PubMed ID: 3398000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Schistosoma mansoni progeny to antischistosomal drugs.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1985; 27(4):186-9. PubMed ID: 3832339
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymatic basis for the lack of oxamniquine activity in Schistosoma haematobium infections.
    Pica-Mattoccia L; Novi A; Cioli D
    Parasitol Res; 1997; 83(7):687-9. PubMed ID: 9272559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
    Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
    Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacological effects in relation to the mode of action of antischistosomal drugs.
    Woolhouse NM
    Biochem Pharmacol; 1979 Aug; 28(16):2413-8. PubMed ID: 41528
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenic activities in vitro and in vivo of five antischistosomal compounds.
    Batzinger RP; Bueding E
    J Pharmacol Exp Ther; 1977 Jan; 200(1):1-9. PubMed ID: 319220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of in vitro RNA synthesis by hycanthone, oxamniquine and praziquantel.
    Wong LJ; Tsao GC; Bruce JI; Wong SS
    Experientia; 1990 May; 46(5):461-4. PubMed ID: 1693342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic activities of hycanthone and some other antischistosomal drugs.
    Ong TM
    Mutat Res; 1978; 55(1):43-70. PubMed ID: 368622
    [No Abstract]   [Full Text] [Related]  

  • 12. [A human strain of Schistosoma mansoni resistant to schistosomicides].
    Dias LC; Pedro RJ; Rigo E; Goto MM; Mafra GL
    Rev Saude Publica; 1978 Mar; 12(1):110. PubMed ID: 675134
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissociation of mutagenic and other toxic properties from schistosomicides.
    Bueding E
    J Toxicol Environ Health; 1975 Nov; 1(2):329-34. PubMed ID: 1206775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase.
    Pica-Mattoccia L; Carlini D; Guidi A; Cimica V; Vigorosi F; Cioli D
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():307-12. PubMed ID: 17308787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimentally produced resistance of Schistosoma mansoni to hycanthone.
    Jansma WB; Rogers SH; Liu CL; Bueding E
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):926-36. PubMed ID: 907054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oxamniquine on Schistosoma mansoni: some biological and biochemical observations.
    Goldberg M; Gold D; Flescher E; Lengy J
    Biochem Pharmacol; 1980 Mar; 29(5):838-40. PubMed ID: 20227968
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of correlation between schistosomicidal and anticholinergic properties of hycanthone and related drugs.
    Pica-Mattoccia L; Cioli D
    J Parasitol; 1986 Aug; 72(4):531-9. PubMed ID: 3783347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase.
    Coelho PM; Ribeiro F; Mello RT; Lima e Silva FC; Nogueira-Machado JA
    Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():267-8. PubMed ID: 9921366
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of promutagenic methylation damage in tissue-DNA of mice treated with antischistosomal agents.
    Badawi AF; Awney HA; Mostafa MH
    Cancer Lett; 1993 Dec; 75(3):167-73. PubMed ID: 8313351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hycanthone on the distribution of Schistosoma mansoni in the mouse.
    Jewsbury JM; Homewood CA; Gibson J
    Ann Trop Med Parasitol; 1974 Sep; 68(3):365-6. PubMed ID: 4447395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.